Angelico Mendy1, Pӓivi M Salo1, Jesse Wilkerson2, Lydia Feinstein2, Kelly K Ferguson1, Michael B Fessler1, Peter S Thorne3, Darryl C Zeldin4. 1. Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA. 2. Social & Scientific Systems, Durham, NC, USA. 3. Department of Occupational and Environmental Health, University of Iowa, Iowa City, IA, USA. 4. Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA. Electronic address: zeldin@niehs.nih.gov.
Abstract
BACKGROUND: Bisphenols F (BPF) and S (BPS) are bisphenol A (BPA) analogs used as substitutes in consumer products. Despite previous reports of BPA's association with asthma, no studies have examined its structural analogs in relation to asthma and allergy outcomes. OBJECTIVE: To examine the association of urinary BPF, BPS, and BPA with asthma and hay fever in a US representative sample. METHODS: We analyzed data from 3,538 participants aged 12 years or older in the 2013-2016 National Health and Nutrition Examination Survey (NHANES). Children aged 6-11 years (N = 738), who did not have all covariate data available, were analyzed separately. Covariate-adjusted logistic regression was used to assess the association of the exposures with the outcomes. RESULTS: BPF, BPS, and BPA were detected in 57.1%, 88.4%, and 94.8% of the urine samples, respectively. Urinary BPF detection was positively associated with current asthma (odds ratio [OR]: 1.54, 95% confidence interval [CI]: 1.16-2.04) and hay fever (OR: 1.66, 95% CI: 1.12-2.46). Urinary BPS was associated with increased odds of current asthma in men (OR: 1.64, 95% CI: 1.13-2.40) and urinary BPA was associated with increased odds of asthma without hay fever in children aged 6-11 years (OR: 2.65, 95% CI: 1.05-6.68). CONCLUSION: Our nationally-representative findings document that BPF and BPS exposure is common in the US and that exposure to these BPA analogs is associated with asthma and/or hay fever. Our results suggest that BPF and BPS may not be safe alternatives to BPA; however, prospective studies should be conducted to confirm these results. Published by Elsevier Inc.
BACKGROUND:Bisphenols F (BPF) and S (BPS) are bisphenol A (BPA) analogs used as substitutes in consumer products. Despite previous reports of BPA's association with asthma, no studies have examined its structural analogs in relation to asthma and allergy outcomes. OBJECTIVE: To examine the association of urinary BPF, BPS, and BPA with asthma and hay fever in a US representative sample. METHODS: We analyzed data from 3,538 participants aged 12 years or older in the 2013-2016 National Health and Nutrition Examination Survey (NHANES). Children aged 6-11 years (N = 738), who did not have all covariate data available, were analyzed separately. Covariate-adjusted logistic regression was used to assess the association of the exposures with the outcomes. RESULTS:BPF, BPS, and BPA were detected in 57.1%, 88.4%, and 94.8% of the urine samples, respectively. Urinary BPF detection was positively associated with current asthma (odds ratio [OR]: 1.54, 95% confidence interval [CI]: 1.16-2.04) and hay fever (OR: 1.66, 95% CI: 1.12-2.46). Urinary BPS was associated with increased odds of current asthma in men (OR: 1.64, 95% CI: 1.13-2.40) and urinary BPA was associated with increased odds of asthma without hay fever in children aged 6-11 years (OR: 2.65, 95% CI: 1.05-6.68). CONCLUSION: Our nationally-representative findings document that BPF and BPS exposure is common in the US and that exposure to these BPA analogs is associated with asthma and/or hay fever. Our results suggest that BPF and BPS may not be safe alternatives to BPA; however, prospective studies should be conducted to confirm these results. Published by Elsevier Inc.
Entities:
Keywords:
Allergy; Asthma; Bisphenol; Bisphenol A substitutes; Endocrine disrupting chemicals; Hay fever
Authors: Vincent Le Fol; Selim Aït-Aïssa; Manoj Sonavane; Jean-Marc Porcher; Patrick Balaguer; Jean-Pierre Cravedi; Daniel Zalko; François Brion Journal: Ecotoxicol Environ Saf Date: 2017-04-11 Impact factor: 6.291
Authors: Stephen M Bauer; Anirban Roy; Jason Emo; Timothy J Chapman; Steve N Georas; B Paige Lawrence Journal: Toxicol Sci Date: 2012-07-21 Impact factor: 4.849
Authors: M M Youssef; Ems El-Din; M M AbuShady; N R El-Baroudy; T A Abd El Hamid; A F Armaneus; A S El Refay; J Hussein; D Medhat; Y A Latif Journal: Hum Exp Toxicol Date: 2018-02-14 Impact factor: 2.903
Authors: Iain A Lang; Tamara S Galloway; Alan Scarlett; William E Henley; Michael Depledge; Robert B Wallace; David Melzer Journal: JAMA Date: 2008-09-16 Impact factor: 56.272
Authors: Adam J Spanier; Robert S Kahn; Allen R Kunselman; Eric W Schaefer; Richard Hornung; Yingying Xu; Antonia M Calafat; Bruce P Lanphear Journal: JAMA Pediatr Date: 2014-12 Impact factor: 16.193
Authors: George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth Journal: J Am Soc Nephrol Date: 2009-01-21 Impact factor: 10.121
Authors: Christina Tsitsimpikou; Nikolaos Georgiadis; Konstantinos Tsarouhas; Panagiotis Kartsidis; Eleni Foufa; Flora Bacopoulou; Athanasios Choursalas; Dimitrios Kouretas; Alexandros K Nikolaidis; Elisabeth A Koulaouzidou Journal: Int J Environ Res Public Health Date: 2021-12-08 Impact factor: 3.390